Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients

Transplant Immunology

Volumn 15, Issue 3, 2006, Pages 223-227

  Shaiegan, Mojgan ^a   Iravani, Masoud ^b   Babaee, Gholam Reza ^c   Ghavamzadeh, Ardeshir ^b  

^a IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

aGVHD; ELISA; HSCT; IL 18; sIL 2R

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 18; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-18; IRAN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; TIME FACTORS;

EID: 31144431851     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2005.10.002     Document Type: Article

References (19)

1. D. Arnold, C. Wesem, P. Juillard, P. Graber, I. Cima, and C. Frutschi IL-18-independent cytotoxic T lymphocyte activation and IFN-gamma production during experimental acute graft-versus-host disease Int Immunol 14 5 May 2002 503 511
2. D.H. Fowler, and R.E. Gress Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma Leuk Lymphoma 38 3-4 Jul 2000 221 234
3. Y. Fujimori, H. Takatsuka, Y. Takemoto, H. Hara, H. Okamura, and K. Nakanishi Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation Br J Haematol 109 3 Jun 2000 652 657
4. M. Imamura Immunological reconstitution and immunoregulatory cells in hematopoietic stem cell transplantation Int J Hematol 76 Suppl 1 Aug 2002 191 194
5. L.M. Liem, H.C. van Houwelingen, and E. Goulmy Serum cytokine levels after HLA-identical bone marrow transplantation Transplantation 66 7 Oct 15 1998 863 871
6. X. Ju, and J. Wang Roles of cytokines in acute graft-versus-host disease Zhongguo Shi Yan Xue Ye Xue Za Zhi 8 4 Dec 2000 312 316
7. J.A. Gracie, S.E. Robertson, and I.B. McInnes Interleukin-18 J Leukoc Biol 73 2 Feb 2003 213 224
8. P. Reddy, T. Teshima, G. Hildebrandt, D.L. Williams, C. Liu, and K.R. Cooke Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects Blood 101 7 Apr 1 2003 2877 2885
9. P. Reddy, and J.L. Ferrara Role of interleukin-18 in acute graft-vs-host disease J Lab Clin Med 141 6 Jun 2003 365 371
10. P. Reddy, T. Teshima, M. Kukuruga, R. Ordemann, C. Liu, and K. Lowler Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis J Exp Med 194 10 Nov 19 2001 1433 1440
11. G. Zecchina, D. Novick, and M. Rubinstein Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants J Hematother Stem Cell Res 10 6 Dec 2001 769 776
12. H. Itoi, Y. Fujimori, H. Tsutsui, K. Matsui, S. Futatsugi, and H. Okamura Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease Blood 98 1 Jul 1 2001 235 237
13. R. Foley, S. Couban, and I. Walker Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation Bone Marrow Transplant 21 8 Apr 1998 769 773
14. J.L. Ferrara, K.R. Cooke, L. Pan, and W. Krenger The immunopathophysiology of acute graft-versus-host-disease Stem Cells 14 5 Sep 1996 473 489
15. S. Scholl, H.G. Sayer, L.O. Mugge, C. Kasper, M. Pietraszczyk, and K.O. Kliche Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation J Cancer Res Clin Oncol 130 12 Dec 2004 704 710
16. J. Grimm, W. Zeller, and A.R. Zander Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD Bone Marrow Transplant 21 1 Jan 1998 29 32
17. C. Mathias, R. Mick, S. Grupp, K. Duffy, F. Harris, and G. Laport Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation J Hematother Stem Cell Res 9 3 Jun 2000 393 400
18. S. Kobayashi, M. Imamura, S. Hashino, J. Tanaka, and M. Asaka Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease Leuk Lymphoma 28 1-2 Dec 1997 159 169
19. H. Nakamura, K. Komatsu, M. Ayaki, S. Kawamoto, M. Murakami, and N. Uoshima Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation J Allergy Clin Immunol 106 1 Pt 2 Jul 2000 S45 S50